Subscribe to our YouTube Channel AGT’s Jeff Galvin speaks on panel at the BIO CEO & Investor Conference on Feb 10-11. The panel discussed IPO trends and outlook for 2020. The 2020 BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private…

Is the cure for cancer right around the corner?… Advances in gene technologies and the resulting cures are accelerating exponentially while costs are coming down. If you were in Silicon Valley for the last 35 years, you’d recognize parallels to many previous high-tech “explosions” such as microcomputers, software and the Internet. “Moore’s Law” now applies…

Written By:  Shennekia Grimshaw  On: LocalDVM ROCKVILLE, MD. — – Local officials held a discussion on the current state and breakthrough of regenerative medicine, which is a cell therapy that aims to treat diseases.   Regenerative medicine is a broad field that deals with gene and cell therapy or regrowing and the replacement of human tissue.   “I’m highly…

Overview Bob Preti and Janet Lynch Lambert, chairman and CEO of the Alliance for Regenerative Medicine (ARM), presented the “State of the Industry” briefing at the 2018 JP Morgan Healthcare Conference, the premier investment conference for biotech, healthcare, and pharmaceutical industries. ARM’s mission is to advance regenerative medicine. It is a global organization that brings together all stakeholders in…

C. David Pauza, PhD,  Former Chief Science Officer at American Gene Technologies (AGT) and Adjunct Professor at the University of Maryland, presented at The Cell and Gene Meeting on the Mesa conference hosted by Alliance for Regenerative Medicine(ARM).  His presentation focused on the HIV cure AGT is working towards (clinical trials beginning in 2018), and how research is opening…